Singular Genomics Systems, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Singular Genomics Systems, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
  • Singular Genomics Systems, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.17M, a 22.5% decline year-over-year.
  • Singular Genomics Systems, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11.4M, a 16.6% decline from 2022.
  • Singular Genomics Systems, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.7M, a 48.1% increase from 2021.
  • Singular Genomics Systems, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.23M, a 771% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.17M -$629K -22.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q1 2024 $11.2M $2.9M -$185K -6.01% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $11.4M $2.69M -$412K -13.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $11.8M $2.79M -$605K -17.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $12.4M $2.84M -$763K -21.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $13.2M $3.08M -$485K -13.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $13.7M $3.1M +$164K +5.59% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $13.5M $3.4M +$540K +18.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $13M $3.61M +$1.26M +54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $11.7M $3.57M +$2.47M +225% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $9.23M $2.94M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.86M +$2.59M +955% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $2.34M +$2.08M +800% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $271K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $260K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.